Monday, April 12, 2010

Update on Pirfenidone

I've been slogging through the hundreds of e-mails I couldn't get to on the road and found some news stories giving an update on the status of Pirfenidone, the drug we had been studying to treat the pulmonary fibrosis of Hermansky-Pudlak Syndrome.

The European Medicines Agency - their version of the Food and Drug Administration - have accepted and validated the application for Pirfenidone. That means, essentially, that the application is complete and that the agency is now going to start reviewing approval of the drug.

It's one more step on the road - we'll see what happens.

No comments: